prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - left breast. Material collected on: I. Expected time of examination: up to 8 working days. Clinical diagnosis: Bifocal cancer of the left breast. Simple mastectomy. Results of immunohistochemical examination: Focus marked as R1: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Negative reaction in invasive cancerous cells. (Score = 1+). Focus marked as R2: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in 10-75% of neoplastic cell nuclei. HER2 protein stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Negative reaction in invasive cancerous cells. (Score = 1+). Compliance valid. Macroscopic description: Carcinoma ductale bifocale - NHG2 (3 + 2+1:0 mitoses/ 10 HPF, visual area diameter: 0,55 mm). Carcinoma ductale in situ (DCIS) within the tumours (solid and cribrate type with high nuclear atypia, and point and comedo. necrosis, 10% of the tumour areas). Invasio carcinomatosa vasorum. In situ lesion of the type cancerisatio lobulorum. Mamilla sine laesionibus. Glandular tissue showing parenchymal atrophy. Examination: Histopathological examination. page 2 / 2. Gender: F. Histopathological diagnosis: Carcinoma ducale bifocale invasivum et in situ mammae sinistrae. Invasive bifocal ductal carcinoma and carcinoma in situ of the. left breast (NHG2, pTic, pNO (SN)). Invasio carcinomatosa vasorum. Vascular invasion. Compliance valida.

expanded version (tokens=865) : 
 Histological classification: 
The pathological diagnosis reveals that the patient has invasive bifocal ductal carcinoma and carcinoma in situ of the left breast. The invasive carcinoma is of the ductal type and has a histological grade of NHG2.

Subtype: 
The subtype of the cancer is LumA, which typically indicates a hormonal receptor-positive breast cancer.

Description of any necrosis: 
The report mentions that the carcinoma in situ has necrosis in the form of point and comedo.

Tumor infiltrating lymphocytes: 
There is no mention of tumor-infiltrating lymphocytes in the report.

Histological grade / Nuclear grade: 
The invasive carcinoma is graded as NHG2, indicating moderate to high-grade malignancy. The report also states that the invasive carcinoma has a nuclear grade of 3 (on a scale of 1-3).

Lymphovascular invasion: 
The report mentions that there is invasion of the vasculature by the invasive carcinoma.

Calcification: 
No information on calcification is found in the report.

Receptor status: 
The report states that the patient's neoplastic cells have estrogen receptors present in over 75% of neoplastic cell nuclei and progesterone receptors present in 10-75% of neoplastic cell nuclei. HER2 protein was stained, and the result was negative for invasive cancer cells.

IHC and ancillary testing results: 
The report states that HER2 protein was tested using a rabbit antibody Vent

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1027) : 
 Histopathological examination of a patient's left breast reveals bifocal LumA subtype infiltrating ductal carcinoma and carcinoma in situ. Necrosis is present in the form of point and comedo. The invasive carcinoma has a histological grade of NHG2 and nuclear grade 3. Invasion of the vasculature is observed, while no tumor-infiltrating lymphocytes are mentioned. Estrogen receptors are found in over 75% of neoplastic cell nuclei and progesterone receptors found in 10-75%. HER2 protein tested negative using IHC.

